SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : Network Associates (NET)
NET 200.54-1.7%3:03 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: mark mallen who wrote (1062)9/18/1997 2:26:00 PM
From: AlienTech   of 6021
 
I still say, short everything in sight and buy DELL!!! At least they dont make anything their own except the name..

Dr Solomon's Software Uses Facts to Correct McAfee's Fabricated Sales Claims Independent Sales Numbers Verify Dr Solomon's Continued Strength In UK and US Retail Markets
PR Newswire - September 18, 1997 14:13
SOLLY %CPR V%PRN P%PRN

--------------------------------------------------------------------------------

Jump to first matched term BURLINGTON, Mass., Sept. 18 /PRNewswire/ -- Dr Solomon's Software
(Nasdaq: SOLLY) (Easdaq: SOLL), the worldwide leader in computer virus
detection, identification and disinfection, today refuted and corrected market
performance measures reported yesterday in a press release issued by McAfee
Associates (Nasdaq: MCAF). The corrected figures confirm Dr Solomon's
continued strength in European markets as well as its growing presence in
North America.
McAfee's press release had claimed that Romtec, a leading UK market
analyst firm, had reported that McAfee's product outsold Dr Solomon's Anti-
Virus Toolkit in its most recently published retail sales figures. However,
the facts are quite different. According to Chris Herbert, Business Manager
at Romtec, "Dr Solomon's Anti-Virus Toolkit clearly outsold McAfee's VirusScan
in the U.K. indirect channel in July."
McAfee's press release further claimed Dr Solomon's Software was absent
from a Top 200 list of vendors published by PC Data Corporation, provider of
the most accurate, reliable and comprehensive software and hardware point-of-
sale information in North America. Again, this is completely untrue. In
fact, the most recently available July sales numbers from PC Data show:

-- Dr Solomon's Software holds the No. 59 position for overall software
sold;
-- Dr Solomon's Anti-Virus, its US retail product, earned the No. 18
position in the business software category; and
-- Dr Solomon's Software held the No. 20 position for business software
units sold.

"Dr Solomon's Software has earned a spot in our Top 200 publisher's list
every month since April -- just one month after its entry into the U.S. retail
marketplace," said Ann Stephens, president of PC Data. "The company currently
holds the No. 59 position for overall U.S. retail software sales."

Company Background
Dr Solomon's Software, the worldwide leader in computer virus detection,
identification and disinfection, is an international company founded in 1984.
The company is recognized for its technically-superior corporate anti-virus
solution -- Dr Solomon's Anti-Virus Toolkit, a cross-platform set of products
with an installed base exceeding 3 million worldwide, and which detects more
than 14,000 currently known viruses. Dr Solomon's anti-virus solutions are
certified by the National Computer Security Association and have furthermore
been certified to Secure Computing Checkmark standards.
Dr Solomon's Software employs more than 400 staff worldwide with offices
in Burlington, Massachusetts, USA; Aylesbury, UK; Hamburg, Germany; Basel,
Switzerland; and Melbourne, Australia. In addition, Dr Solomon's products are
distributed by 58 international partners in 98 countries. Worldwide bookings
for the year ended May 31, 1997 exceeded $72 million. For more information,
call toll-free 888-DRSOLOMON or 781-273-7400 in the U.S., +49 (0) 40 25 19 54-
0 in Germany, or +44 (0)1296 318 700 in the U.K. or elsewhere, or visit the Dr
Solomon's Web site at www.drsolomon.com. For investor information, please
contact Shandwick Consultants Limited at +44 (0)171 329 0096.

SOURCE Dr Solomon's Software
CONTACT: Michael Quint, Alexander Communications, 404-897-2300 or email:
mquint@alexander-pr.com or Stephen Orenberg, Dr Solomon's Software,
781-273-7422 or email: steve.orenberg@drsolomon.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext